S&P 500 Industrials Sector SEC Filings — April 01, 2026

01-04-2026

Lakewood-Amedex Biotherapeutics Inc. (LABT) filed Amendment No. 4 to its Form S-1 registration statement on April 1, 2026, for a direct listing on the Nasdaq Capital Market under the symbol LABT, registering 4,689,177 shares of common stock for resale by existing stockholders, from which the company will receive no proceeds. The company engaged RBW Capital Partners LLC as financial advisor (to receive 272,219 unregistered shares equal to 1.75% of fully diluted shares outstanding) and placement agent (7% fee) for a concurrent private placement of 937,500 shares of Series C Preferred Stock at $10.00 per share, raising $7,500,000 gross proceeds prior to listing. The direct listing process is novel and may result in volatile trading, with Nasdaq approval required and no assurance of listing success.

• ·Series C Preferred Stock stated value $10.00 per share, convertible into common stock at lower of $10.00 or 80% of 5-day average closing price (floor $1.00).
• ·Company classified as emerging growth company and smaller reporting company, electing reduced reporting requirements.
• ·Resale registration statement for Series C underlying common stock and advisory shares to be filed within 10 days of Nasdaq listing.
• ·Listing contingent on Nasdaq approval; if not approved, direct listing will be terminated.

01-04-2026

Community West Bancshares (CWBC) completed its merger with United Security Bancshares (UBFO) on April 1, 2026, in an all-stock transaction where UBFO shareholders received 0.4520 CWBC shares per UBFO share, valued at approximately $185.5 million based on CWBC's $23.30 closing price on March 31, 2026. The combined company has approximately $5 billion in total assets, retains banking offices across 13 counties and 31 communities in Central California, and features a 14-member board with 12 directors from CWBC and 2 from UBFO. Leadership transitions include James J. Kim as CEO and President, Daniel J. Doyle as Chairman, new Vice Chairman Jagroop “Jay” Gill, and Dennis R. Woods as Chairman Emeritus, alongside retirements of Suzanne M. Chadwick, Tom L. Dobyns, William S. Smittcamp, and upcoming Daniel C. Cunningham.

• ·Shareholder approvals at special meetings on March 30, 2026.
• ·Planned systems conversion in summer 2026.
• ·Exchange ratio: 0.4520 shares of CWBC common stock per share of UBFO common stock.
• ·This is the seventh acquisition for the company, following Community West Bancshares (2024), Folsom Lake Bank (2017), Sierra Vista Bank (2016), Visalia Community Bank (2013), Service 1st Bank (2008), and Bank of Madera County (2005).

01-04-2026

Medalist Diversified REIT, Inc. completed dispositions of five properties in late 2025 and early 2026, including Greenbrier Property for $11,000,000, Parkway Property for $7,825,000, and Franklin Square Property for $24,100,000, using proceeds to repay approximately $24 million in mortgages and boosting cash to $19,483,519 on the pro forma balance sheet as of December 31, 2025. Total assets decreased to $65,467,891 with investment properties net at $25,723,677 and mortgages payable reduced to $19,709,183, improving shareholders' equity to $15,890,259. However, the pro forma statement of operations for the year ended December 31, 2025 shows total revenue declining 55% to $4,724,834 and net loss attributable to common shareholders widening to $(3,396,461) or $(2.70) per share from historical $(1.90).

• ·Salisbury Property disposed October 23, 2025; Buffalo Wild Wings and United Rentals Properties disposed December 30, 2025; Greenbrier February 13, 2026; Parkway February 27, 2026; Franklin Square March 30, 2026.
• ·Pro forma loss per share $(2.70) basic and diluted; historical $(1.90).
• ·Pro forma accumulated deficit $(32,300,582) improved from historical $(38,761,731).

01-04-2026

Charlotte’s Web Holdings entered a subscription agreement with BAT for a US$10 million equity investment via up to 14.8 million common shares and will amend its existing US$54 million convertible debenture (originally issued 2022) to lower the conversion price to C$0.94/share and raise the ownership cap from 19.9% to 40.8%, enabling conversion into 95.3 million shares upon closing around May 28, 2026. This represents a total US$75 million equity commitment from BAT, providing critical capital. However, it causes significant shareholder dilution (outstanding shares rising from 159.7 million to 269.7 million) and grants BAT proportional board nomination rights (minimum 2 directors if >=10% ownership), pre-emptive rights, top-up rights, and veto powers over key actions like indebtedness >US$10 million.

• ·Convertible Debenture interest: 5% until US federal CBD regulation in food/supplements, then 1.5%; matures November 14, 2029
• ·BAT standstill provision for 2 years post-Amended IRA (no actions to reach 49%+ ownership)
• ·BAT share transfer restriction for 18 months post-Amended IRA (with exceptions)
• ·BAT demand registration rights: up to 3 times total, once per 12 months
• ·Subscription Agreement dated March 30, 2026; original debenture November 14, 2022

01-04-2026

Innate Pharma SA's revenue from collaboration and licensing agreements plummeted 78% YoY to €2,787 thousand in 2025 from €12,622 thousand in 2024, driving total revenue and other income down 55% to €9,005 thousand, while government financing for research declined 17% to €6,205 thousand. R&D expenses decreased 16% to €43,620 thousand and G&A expenses edged down 2% to €19,394 thousand, but operating loss widened 5% to €54,008 thousand; net loss remained nearly flat at €49,177 thousand, buoyed by net financial income rising 130% to €4,831 thousand.

• ·Proceeds from monalizumab agreement with AstraZeneca: €220 thousand in 2025 (down from €4,404 thousand in 2024)
• ·Sanofi agreement 2022 - ANKET IPH62: €400 thousand in 2025 (similar to €401 thousand in 2024)
• ·R&D sub-total programs in clinical development: €18,231 thousand in 2025 (down from €25,565 thousand in 2024)
• ·IPH4502 R&D expenses: €3,405 thousand in 2025 (down sharply from €9,695 thousand in 2024)
• ·Restructuring costs in R&D: €2,306 thousand in 2025 (none in 2024)
• ·Foreign exchange gains drove financial income higher: €5,883 thousand in 2025 vs €1,658 thousand in 2024

01-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on April 1, 2026, under Item 8.01 announcing the issuance of a press release titled 'AITX's RAD Retained Through Property Sale as New Owner Validates Autonomous Security Performance.' The press release, attached as Exhibit 99.1, highlights the retention of AITX's RAD system by a property's new owner post-sale, validating its autonomous security capabilities. No financial metrics or period comparisons were disclosed.

• ·Filing is furnished under Item 8.01 and not deemed 'filed' for liability purposes.
• ·Registrant details: Nevada incorporation, CIK 0001498148, EIN 27-2343603, principal office at 10800 Galaxie Avenue, Ferndale, Michigan 48220.

01-04-2026

Golden Entertainment, Inc. held a special shareholder meeting on March 31, 2026, approving the Master Transaction Agreement (MTA) entered on November 6, 2025, with Argento, LLC, VICI Properties Inc., and VICI ROYAL MERGER SUB LLC by a strong majority (20,430,245 votes for vs. 208,131 against). Advisory approval for executive compensation passed (18,321,781 for vs. 2,330,138 against), and the adjournment proposal also approved overwhelmingly (19,538,974 for), though not needed. Approximately 78% of the 26,398,811 outstanding shares were present, meeting quorum requirements.

• ·Record date for special meeting: March 3, 2026
• ·Definitive Proxy Statement filed and mailed: March 6, 2026
• ·No broker non-votes for any proposal

01-04-2026

WidePoint Corp (WYY) filed an 8-K on April 01, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), attaching a transcript of their earnings call as Exhibit 99.1. No specific financial metrics, period-over-period comparisons, or performance details are provided in the filing content. The subcategory mentions Unregistered Securities Sale, but the exhibit focuses on the earnings call transcript.

• ·Filing Type: 8-K
• ·Subcategory: Unregistered Securities Sale

01-04-2026

Global Net Lease, Inc. declared a dividend of $0.190 per share on its common stock, payable on April 17, 2026, to holders of record as of the close of business on April 13, 2026. The announcement was issued via a press release attached as Exhibit 99.1 under Item 7.01 Regulation FD Disclosure.

• ·Filing date: April 1, 2026
• ·Registrant address: 650 Fifth Avenue, 30th Floor, New York, New York 10019
• ·Telephone: (332) 265-2020

01-04-2026

Golden Growers Cooperative's 10-K/A filing reports net income of $6,059 thousand for the year ended December 31, 2025, up slightly 0.3% YoY from $6,041 thousand, with EPS flat at $0.39 per share/unit. Corn revenue grew marginally 0.5% to $62,279 thousand and net income from ProGold LLC increased 3.6% to $6,461 thousand; however, other income declined 36.5% to $282 thousand, total assets fell 18.5% to $20,283 thousand, and members' equity decreased to $20,095 thousand due to higher distributions of $10,688 thousand. Operating cash flow remained flat at negative $396 thousand YoY.

• ·All directors are independent based on defined criteria.
• ·Net cash used in operating activities flat at $(396) thousand YoY.
• ·ProGold LLC total assets $28,297 thousand as of Dec 31, 2025 (down from $31,262 thousand).

01-04-2026

Faraday Future reported Q4 and FY 2025 results with stockholders’ equity turning positive at $7.7 million after ~$100 million debt optimization and financing cash inflow of $161.4 million, up 100% YoY from $80.7 million. EAI Robotics exceeded first-month targets with 22 units shipped and positive product gross margins in Q1 2026, while achieving the first FX Super One pre-production vehicle roll-off. However, revenue was flat YoY, operating loss reached $331 million for FY 2025 ($185 million excluding one-time impairments), and operating cash outflow was $107.5 million.

• ·SEC investigation concluded in March 2026 with no enforcement action.
• ·Nasdaq deficiency notice received March 20, 2026, for minimum bid price below $1.00; 180 days to comply.
• ·First FX Super One pre-production vehicle rolled off December 21, 2025, at Hanford, CA AI-Factory.
• ·EAI Robotics targeting >1,000 cumulative shipments by end December 2026.
• ·Headquarters relocated to Silicon Beach, El Segundo, CA in March 2026.
• ·Initiated action on potential illegal short selling and market manipulation in March 2026.

01-04-2026

Total revenue slightly declined 0.2% YoY to $9,739,942 while total expenses rose 12.3% to $16,727,857, leading to a widened net loss of $6,389,000 from $4,872,888 in 2024 and net loss attributable to common shareholders of $10,340,904 (vs. $8,444,487). Core Funds From Operations turned negative at $(37,783) from $179,346, and Adjusted Funds From Operations worsened to $(431,030) from $(42,692); however, Core Adjusted Funds From Operations improved to $1,202,089 from $372,920, supported by a $1,936,446 gain on property sale that increased cash to $6,164,316.

• ·Operating cash flow declined to $929,474 from $1,022,362 YoY.
• ·Cash increased $5.55M net, driven by $23.1M investing inflow from property sale.
• ·Stockholders' equity shifted to deficit of $4,199,971 from $5,795,933.
• ·Mortgage loans decreased to $48,690,776 from $58,340,234.
• ·Redeemable Non-Controlling Interests increased to $32,187,864 from $26,664,545.

01-04-2026

Signature Wealth Management Group filed a 13F-HR on April 1, 2026, disclosing total holdings valued at $263,370,400 across 128 positions as of March 31, 2026. The portfolio features a diversified mix of individual stocks including AbbVie Inc ($5,259,027, 24,181 shares), Bristol-Myers Squibb Co ($5,080,589, 83,769 shares), and Chevron Corp ($5,788,413, 27,977 shares), alongside significant allocations to fixed income and equity ETFs such as various iShares iBonds series and Vanguard funds. All reported positions are held with sole discretionary voting power.

• ·Portfolio address: 3625 Cumberland Blvd. Suite 1485, Atlanta, GA 30339
• ·Business phone: 678-932-2500

01-04-2026

Dror Ortho-Design, Inc., a dental equipment and supplies company, filed Amendment No. 3 to its Form S-1 registration statement (No. 333-287624) on April 1, 2026, to advance its initial public offering process. The amendment incorporates by reference numerous recent exhibits, including forms of debentures and warrants from securities purchase agreements dated June 2025 through March 2026, employment and services agreements for key executives, and share incentive plans. It also includes new consents from independent auditors Barzily and Co. and legal counsel Haynes and Boone, LLP, with no financial performance metrics disclosed in this filing.

• ·Standard Industrial Classification: Dental Equipment & Supplies [3843]
• ·Fiscal year end: December 31
• ·State of incorporation: Delaware
• ·Business address: 480 Johnson Road, Suite 200, Washington, PA 15301
• ·SEC file number: 333-287624
• ·Original S-1 filed August 14, 2023

01-04-2026

Target Hospitality Corp. filed an 8-K on April 1, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01, announcing a press release with a business update and revised financial outlook. The press release is furnished as Exhibit 99.1 but specific financial details are not included in the filing body. No quantitative metrics or performance changes are disclosed in the provided content.

• ·Filing Type: 8-K
• ·Commission File Number: 001-38343
• ·I.R.S. Employer Identification No.: 98-1378631
• ·Trading Symbol: TH (NASDAQ Capital Market)

01-04-2026

L3Harris Technologies, Inc. filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Shareholders on May 11, 2026, at 9:00 AM ET virtually. Key proposals include election of 11 director nominees (board FOR), advisory approval of named executive officer compensation (board FOR), ratification of Ernst & Young LLP as auditors for FY2026 (board FOR), and a shareholder proposal to improve ability to call special meetings (board AGAINST). Proxy materials are available online at www.ProxyVote.com, with paper/email requests due by April 27, 2026.

• ·Vote deadline: May 10, 2026, 11:59 PM ET via www.ProxyVote.com
• ·Virtual meeting link: www.virtualshareholdermeeting.com/LHX2026
• ·Fiscal year reference: Ended January 2, 2026
• ·Company address: 1025 WEST NASA BOULEVARD, MELBOURNE, FL 32919

01-04-2026

Safe & Green Development Corp's 10-K for the year ended December 31, 2025, shows revenues surging to $8,220,449 from $207,552 in 2024, reflecting strong growth in biomass recycling and new business lines. However, the net loss widened significantly to $15,957,099 from $8,908,475, driven by higher costs, $3,025,000 in bad debt expenses, $965,812 impairment loss, and increased interest expense of $5,265,549. Cash used in operating activities deteriorated to $7,030,824 from $2,676,353, resulting in a net decrease in cash of $173,700 versus an increase of $224,530 prior year.

• ·Auditors expressed substantial doubt about going concern ability.
• ·Operations concentrated at single permitted facility in Florida, dependent on state permits.
• ·Risk of Nasdaq delisting due to failure to meet continued listing requirements.
• ·No intention to pay dividends on common stock.
• ·Entered February 2026 Purchase Agreement with restrictive covenants.

01-04-2026

UBS Commercial Mortgage Trust 2019-C16 announced that Mount Street US (Georgia) LLP was removed as special servicer for the Colonnade Office Complex Mortgage Loan, which constituted approximately 6.9% of the asset pool as of the cut-off date, and CWCapital Asset Management LLC was appointed as successor special servicer effective April 1, 2026, pursuant to Section 7.01(d) of the UBS 2019-C16 PSA. This change is in the interest of transaction management. No financial performance metrics, improvements, declines, or other impacts were disclosed.

• ·Pooling and Servicing Agreement (PSA) dated April 1, 2019, filed as Exhibit 4.1 to Form 8-K on April 16, 2019.
• ·CWCAM servicing office: 900 19th Street NW, 8th Floor, Washington, D.C. 20006.

01-04-2026

BBCMS Mortgage Trust 2019-C3 filed an 8-K announcing that CWCapital Asset Management LLC (CWCAM) was appointed as successor special servicer for the Colonnade Office Complex Mortgage Loan, which constitutes approximately 3.2% of the asset pool as of the cut-off date, effective April 1, 2026. Mount Street US (Georgia) LLP was removed from this role. The loan is serviced under the UBS Commercial Mortgage Trust 2019-C16 pooling and servicing agreement.

• ·Servicing governed by UBS Commercial Mortgage Trust 2019-C16 PSA, dated April 1, 2019.
• ·CWCAM servicing office: 900 19th Street NW, 8th Floor, Washington, D.C. 20006.
• ·Appointment pursuant to Section 7.01(d) of the UBS 2019-C16 PSA.

01-04-2026

Wells Fargo Commercial Mortgage Trust 2019-C50 filed an 8-K announcing that the Colonnade Office Complex Mortgage Loan, constituting approximately 3.0% of the asset pool as of its cut-off date, will now be specially serviced by CWCapital Asset Management LLC (CWCAM) as successor special servicer, effective April 1, 2026. Mount Street US (Georgia) LLP was removed from this role pursuant to Section 7.01(d) of the UBS 2019-C16 PSA. This change is for transaction management purposes with no reported impact on performance metrics.

• ·Change effective as of April 1, 2026, pursuant to Section 7.01(d) of the UBS 2019-C16 PSA dated April 1, 2019.
• ·CWCAM servicing office: 900 19th Street NW, 8th Floor, Washington, D.C. 20006.
• ·Loan is part of a loan combination serviced and administered under the UBS 2019-C16 PSA.

01-04-2026

Great Lakes Dredge & Dock Corporation filed its Third Amended and Restated Certificate of Incorporation as Exhibit 3.1 to an 8-K, significantly reducing authorized capital stock to 1,000 shares of Common Stock with a par value of $0.0001 per share. The document outlines standard Delaware corporate provisions, including limitations on director and officer liability for breaches of fiduciary duty, comprehensive indemnification rights, and advancement of expenses for directors and officers. This update accompanies 8-K items indicating completion of an acquisition or disposition, changes in control, board departures and elections, and potential delisting or suspension notices.

• ·Registered office: 251 Little Falls Drive, Wilmington, County of New Castle, Delaware 19808
• ·Registered agent: Corporation Service Company
• ·Board has power to amend bylaws

01-04-2026

Enphase Energy, Inc.'s 2026 Proxy Statement details the Annual Meeting on May 13, 2026, for electing three Class II directors (Jamie Haenggi, Benjamin Kortlang, Richard Mora) to serve until 2029, advisory approval of executive compensation, amendment to the 2021 Equity Incentive Plan increasing authorized shares by 2,000,000, and ratification of Deloitte & Touche LLP as auditors for FY 2026. FY 2025 financials show net revenues of $1.5 billion, GAAP gross margin of 46.6% (Non-GAAP 48.2%), and GAAP net income of $172.1 million (Non-GAAP $389.8 million), with operational highlights including 2,872 employees, over 86 million microinverters shipped (30.9 GW), and 2.39 GWh energy storage systems shipped. No declines or flat metrics are reported in the provided highlights.

• ·Annual Meeting date: May 13, 2026, at 9:00 a.m. Pacific Time, at 47281 Bayside Parkway, Fremont, CA 94538.
• ·Record date: March 19, 2026.
• ·Over 1,900 installers in the Enphase Installer Network as of December 31, 2025.
• ·Stockholder outreach engaged ~64.2% of outstanding shares (32 stockholders contacted), with 35.4% responding.

01-04-2026

Whirlpool Corporation reported the termination of James Peters' employment on March 30, 2026, after he stepped down from his roles as Executive Vice President, Chief Financial and Administrative Officer, and President, Whirlpool Asia, effective January 1, 2026, as part of ongoing talent planning. Under the Waiver and Release Agreement, Peters will receive $3,046,500 in severance payments in two installments, eligibility for a prorated 2026 annual incentive award, and vesting of 20,000 restricted stock units contingent on compliance with waivers, restrictive covenants, and cooperation obligations.

• ·First severance installment payable within 30 days of March 30, 2026; second in March 2027.
• ·Prorated annual incentive under 2026 Executive Performance Excellence Plan determined in February 2027 based on target percentage and company performance.
• ·Restrictive covenants in effect for two years post-termination; ongoing cooperation covenant.

01-04-2026

Horizon Bancorp, Inc. (HBNC) announced a conference call on April 23, 2026, at 7:30 a.m. CT to review its first quarter 2026 financial results, with the news release to be published after markets close on April 22, 2026. The company reports $6.4 billion in assets as of December 31, 2025. No financial results or performance metrics were disclosed in this announcement.

• ·Conference call dial-in: 1-833-974-2379 (US/Canada) or 1-412-317-5772 (international).
• ·Replay available through May 23, 2026, via 1-855-669-9658 (US/Canada) or 1-412-317-0088 (international), access code 2139263.

01-04-2026

On March 31, 2026, Design Therapeutics, Inc. appointed David Shapiro, M.D. as a Class III director, effective immediately, with a term ending at the 2027 annual meeting of stockholders. Dr. Shapiro was also appointed to the Nominating and Corporate Governance Committee. Compensation includes annual cash retainers of $40,000 for Board service and $5,000 for Committee service, plus an initial option grant for 60,000 shares vesting over three years and a prorated grant for 7,500 shares vesting over one year.

• ·Initial option grant vests monthly over a three-year period.
• ·Prorated annual option grant vests monthly over a one-year period.
• ·Company entered into standard indemnification agreement with Dr. Shapiro.

01-04-2026

On March 26, 2026, Bunge Global SA's Board of Directors approved the Executive Integration Incentive Program, a one-time performance-based restricted stock unit (PBRSU) plan for senior officers including the CEO, tied to cumulative run-rate cost synergy targets from the Viterra Limited acquisition integration over the 2026-2028 performance period. Key grants include 63,281 PBRSUs to CEO Gregory Heckman, 19,501 to COO Julio Garros, 12,099 to CFO John Neppl, 7,959 to EVP Christos Dimopoulos, and 3,900 to Chief Legal Officer Joseph Podwika. PBRSUs vest upon performance certification and continued employment through settlement.

• ·Performance period: January 1, 2026 to December 31, 2028, based on cumulative run-rate cost synergy targets.
• ·Vesting subject to Compensation Committee certification, continued employment, and for CEO/CFO, compliance with shareholder-approved Executive Management Team compensation cap.

01-04-2026

Cottonwood Communities, Inc. reported sales of 239,119 shares of Series A Convertible Preferred Stock for $2,369,181 in gross proceeds during March 11-31, 2026, with $124,160 in commissions and $68,522 in placement fees paid. Additionally, the company sold 130,077 shares of Series 2025 Preferred Stock for $1,277,000 in gross proceeds over March 16-31, 2026, incurring $55,620 in commissions and $37,872 in placement fees. These sales are part of ongoing private placements with maximum offerings of $150,000,000 each.

• ·Offerings exempt under Rule 506(b) of Regulation D, sold solely to accredited investors without general solicitation.
• ·Series A Convertible launched September 19, 2023; Series 2025 launched December 9, 2024; both at $10.00 per share.

01-04-2026

Chain Bridge I, a SPAC, reported total assets declining to $1,183,329 at December 31, 2025 from $5,442,658 YoY, primarily due to Investments held in Trust Account dropping 85.5% to $766,224 from $5,285,060 amid heavy redemptions of Class A ordinary shares (62,590 shares remaining vs. 455,736). While cash rose 201% to $390,255, total liabilities increased 72% to $4,282,588 and accumulated deficit worsened 63% to $(3,866,058) from $(2,367,244), driven by higher accrued expenses, new Senior Note debt of $1,078,066, and elevated derivative liabilities.

• ·Class A redeemable shares at $12.242 per share (2025) vs. $11.377 (2024).
• ·New Senior Note of $1,078,066 issued in 2025.
• ·Accrued expenses – related party cleared to $0 from $120,000.
• ·Derivative liabilities increased to $557,870 from $88,200.

01-04-2026

ARMOUR Residential REIT, Inc. confirmed the April 2026 cash dividend for its Common Stock at $0.24 per share (record date April 15, 2026; payment date April 29, 2026), consistent with guidance released on March 25, 2026. The Company also confirmed Q2 2026 monthly cash dividends for Series C Preferred Stock at $0.14583 per share for April (payment April 27), May (payment May 27), and June (payment June 29). Dividends are determined at the Board's discretion considering results of operations, cash flows, financial condition, and market conditions.

• ·ARMOUR has elected to be taxed as a REIT and must distribute substantially all ordinary REIT taxable income to maintain status.
• ·Dividends in excess of current tax earnings and profits are generally not taxable to common stockholders.
• ·Investor contact: Gordon M. Harper at (772) 617-4340; Company address: 3001 Ocean Drive, Suite 201, Vero Beach, Florida 32963.

01-04-2026

Grayscale Bittensor Trust (TAO) issued 121,300 Shares to accredited investors via private placements exempt under Rule 506(c) since its last 10-K, receiving an aggregate of 2,322.50581174 TAO valued at $715,103, with Grayscale Securities, LLC acting as Authorized Participant. No underwriting discounts or commissions were paid. Total Shares outstanding now stand at 2,002,800 as of April 1, 2026.

• ·Event reported as of March 28, 2026; filing dated April 1, 2026
• ·Shares issued at prices determined by reference to NAV per Share

01-04-2026

Valhi, Inc. (VHI) has issued a Definitive Additional Proxy Statement (DEFA14A) notice for its Annual Meeting of Stockholders on May 21, 2026, at 10:00 a.m. Central Time at Three Lincoln Centre Conference Center in Dallas, Texas. Shareholders are to vote on the election of seven director nominees (Thomas E. Barry, Loretta J. Feehan, Terri L. Herrington, W. Hayden Mcllroy, Gina A. Norris, Michael S. Simmons, and Mary A. Tidlund) and a nonbinding advisory vote approving named executive officer compensation, with the Board recommending a vote FOR all items. Proxy materials are available online at www.envisionreports.com/VHI, paper copy requests due by May 7, 2026, and electronic votes must be received by 11:59 p.m. ET on May 20, 2026.

• ·Meeting location: Three Lincoln Centre Conference Center, 5430 LBJ Freeway, Suite 350, Dallas, Texas 75240-2620.
• ·Proxies authorized to vote in discretion on other business properly coming before the meeting or any adjournment.

01-04-2026

Gentherm Incorporated filed Definitive Additional Materials (DEFA14A) with the SEC on April 01, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is part of the proxy solicitation process for the registrant. No specific proposals, financial data, or other substantive details are provided in the available content.

01-04-2026

China Pharma Holdings, Inc. reported revenue of $4,144,268 for FY 2025, down 8.5% YoY from $4,528,929, amid a sharp reduction in cost of revenue that narrowed the gross loss to $131,950 from $1,985,648; however, operating expenses rose 19.4% to $3,107,128 driven by higher G&A costs. Net loss improved 32.7% to $3,187,556 from $4,736,365, with positive operating cash flow of $148,261 versus a prior outflow of $406,063, though cash and equivalents declined to $345,112 from $626,879. Total assets doubled to $30,999,464, bolstered by $17,916,400 in intangible assets acquired via stock issuance, increasing shares outstanding to 15,522,002.

• ·Trade accounts receivable gross declined to $254,435 from $13,819,322, with $13,664,945 written off to allowance.
• ·Inventories provision for obsolescence increased to $1,145,240 from $574,071.
• ·Weighted average shares outstanding increased to 4,291,427 from 1,746,372; basic and diluted EPS improved to $(0.74) from $(2.71).

01-04-2026

URBN's FY2026 net sales rose 11.1% YoY to $6,165.4 million, driven by gross profit growth of 15.1% to $2,217.8 million (margin expansion to 36.0%) and operating income surging 27.8% to $605.6 million (9.8% margin). Net income increased 15.5% to $464.9 million ($5.15 basic EPS). However, other expenses jumped to $45.5 million from $4.6 million, and SG&A expenses held flat at 26.2% of sales.

• ·Working capital increased to $568.0 million from $417.1 million.
• ·Share repurchases in FY2026 totaled 3,711,472 shares for $177.0 million inclusive of excise tax.
• ·Net cash used in financing activities widened to $191.4 million from $77.1 million, primarily due to repurchases.
• ·Accumulated other comprehensive loss improved to $(22.1) million from $(46.6) million.

01-04-2026

Laurus Global Equity Management Inc., based in Toronto, Ontario, filed its 13F-HR on April 1, 2026, reporting 46 equity holdings as of March 31, 2026, with a focus on technology, industrials, and financial services sectors. Top positions include Jack Henry & Associates Inc. ($13,170,896), Charles River Laboratories International, Inc. ($12,365,663), PTC Inc. ($11,872,409), and S&P Global Inc. ($11,129,021). All holdings are held with sole voting power and no other managers or options reported.

• ·All positions reported with sole shared investment discretion and voting power; no put/call options, shared voting, or other managers indicated.
• ·Former company name: Laurus Investment Counsel Inc. (name change date: June 24, 2021).

01-04-2026

Andina Bottling Co Inc's 20-F annual report for the year ended December 31, 2025 discloses total capital expenditures of Ch$276,728 million, down 8.5% from Ch$302,519 million in 2024 after a 35.9% YoY increase from Ch$222,620 million in 2023. While Paraguay's capex surged 91.0% YoY to Ch$41,851 million and Brazil remained nearly flat at +0.8% to Ch$115,963 million, declines were noted in Chile (-3.0% to Ch$73,557 million) and a sharp drop in Argentina (-49.4% to Ch$45,357 million). The filing also cautions on risks from legal proceedings and anti-corruption compliance that could impact profitability.

• ·Capital expenditures for Chile in 2023: Ch$107,314 million
• ·Capital expenditures for Brazil in 2023: Ch$54,082 million
• ·Capital expenditures for Argentina in 2023: Ch$44,729 million
• ·Capital expenditures for Paraguay in 2023: Ch$16,495 million

01-04-2026

Bassett Furniture Industries reported fiscal Q1 2026 consolidated net sales of $80.3 million, down 2.2% YoY from $82.2 million, with operating income declining to $1.2 million (1.4% of sales) from $2.5 million (3.0% of sales). While wholesale sales edged up 0.1% to $53.0 million and Bassett Casegoods sales grew 12.1%, retail sales fell 1.4% to $52.5 million with an operating loss of $1.0 million versus breakeven, gross margins dropped 80 basis points to 56.2%, and SG&A expenses rose 70 basis points to 54.7% of sales due to lower sales leverage. Diluted EPS was $0.13, down from $0.21 YoY, though e-commerce sales increased 28% and retail written sales were flat.

• ·Inventories increased to $65,666 thousand from $61,790 thousand quarter-over-quarter.
• ·Total assets stood at $316,154 thousand as of February 28, 2026, down from $323,819 thousand.
• ·Initiatives expected to save $1.5 to $2.0 million annually beginning late Q2 FY26.
• ·Conference call scheduled for April 2, 2026, at 9:00 am ET.

01-04-2026

Aldeyra Therapeutics, Inc. paid off $15 million in outstanding borrowings and terminated all commitments under the Hercules Credit Facility on April 1, 2026, its maturity date. This action fully terminates the facility entered into on March 25, 2019. As previously disclosed, the company's cash, cash equivalents, and marketable securities as of December 31, 2025, are expected to fund operations into 2028.

• ·Hercules Credit Facility originally dated March 25, 2019
• ·Registrant incorporated in Delaware, Commission File No. 001-36332, IRS Employer Identification No. 20-1968197

01-04-2026

NovaBay Pharmaceuticals, Inc. amended its Second Amended and Restated Certificate of Incorporation to change its name to Stablecoin Development Corporation, effective at 4:15 p.m. Eastern Time on April 2, 2026. The Board of Directors adopted the amendment via resolutions under Sections 141 and 242 of the Delaware General Corporation Law, without a stockholder vote. The certificate was signed by CEO Michael Kazley on March 31, 2026.

• ·Corporation originally incorporated on April 19, 2010.
• ·Amendment amends Article I of the Second Amended and Restated Certificate of Incorporation.

01-04-2026

Surrozen, Inc. has issued a proxy statement for its 2026 annual stockholder meeting, to be held virtually on May 13, 2026 at 10:00 a.m. PT, with proposals to elect two directors, ratify Ernst & Young LLP as independent auditors for the year ending December 31, 2026, approve named executive officer compensation on an advisory basis, and vote on the preferred frequency of future say-on-pay votes (Board recommends annually). The record date is March 18, 2026, with 11,486,707 shares of common stock outstanding entitled to vote; quorum requires at least one-third of voting power present or by proxy. No financial results, period-over-period comparisons, or performance metrics are detailed in the filing.

• ·Annual Meeting accessible virtually at www.virtualshareholdermeeting.com/SRZN2026 requiring 16-digit control number to vote.
• ·Proxy voting available by phone (1-800-690-6903), internet (www.proxyvote.com), or mail.
• ·Broker non-votes have no effect on Proposals 1, 3, and 4 but count toward quorum; Proposal 2 is discretionary for brokers.

01-04-2026

abrdn Global Income Fund, Inc. (NYSE American: FCO) adjourned its Special Shareholder Meeting held on April 1, 2026, to April 10, 2026, at 10:00 am Eastern Time, to solicit additional proxies and achieve quorum. Shareholders are voting on an Agreement and Plan of Reorganization with abrdn Asia-Pacific Income Fund, Inc. (NYSE American: FAX) and the subsequent liquidation and dissolution of FCO, with the Board unanimously recommending approval. No financial performance metrics were reported in this filing.

• ·Proxy statement and supplemental materials available on www.sec.gov
• ·Contact: Aberdeen Investments U.S. Closed-End Funds Investor Relations at 1-800-522-5465 or investor.relations@aberdeenplc.com

01-04-2026

IPG Photonics Corporation (IPGP) filed a DEFA14A Definitive Additional Proxy Materials on April 01, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934 under Rule 14a-101. The filing is marked as Definitive Additional Materials with no fee required. No specific proposals, financial data, or voting matters are detailed in the provided content.

• ·Filing categorized as Soliciting Material Pursuant to Section 240.14a-12.

01-04-2026

Diodes Incorporated filed a DEFA14A Definitive Additional Materials proxy statement with the SEC on April 01, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing is marked as submitted by the registrant with no fee required. No specific proxy details, financial data, or voting matters are included in the provided content.

• ·Filing categorized as Definitive Additional Materials under Schedule 14A.